← Back to Search

Educational Intervention for Carcinoma

N/A

Waitlist Available

Led By Electra D Paskett, PhD

Research Sponsored by Ohio State University Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline up to 6 months

Awards & highlights

Study Summary

This trial will educate people about HPV and the available vaccine in order to increase HPV vaccination rates and prevent HPV-related cancers.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline up to 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline up to 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in human papillomavirus (HPV) knowledge

Trial Design

1Treatment groups

Experimental Treatment

Group I: Prevention (educational session, handout, survey)Experimental Treatment3 Interventions

Participants attend educational session about HPV-related cancers, screening, and HPV vaccination and guidelines and receive informational infographic handout on HPV vaccination. Participants also complete surveys pre and post education session over 5 minutes each to assess HPV vaccination status among children of participants, HPV knowledge, and intentions to get the HPV vaccination, and screening among participants. In addition, participants complete surveys over telephone or face-to-face at 3 and 6 months.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Ohio State University Comprehensive Cancer CenterLead Sponsor

321 Previous Clinical Trials

290,108 Total Patients Enrolled

39 Trials studying Carcinoma

3,269 Patients Enrolled for Carcinoma

Electra D Paskett, PhDPrincipal InvestigatorOhio State University Comprehensive Cancer Center

5 Previous Clinical Trials

1,815 Total Patients Enrolled

Media Library

Educational Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04880837 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers currently recruiting volunteers for this experiment?

"Affirmative. Per the details posted on clinicaltrials.gov, this research is actively recruiting participants from one medical centre with a total goal of 100 enrollees. The trial was first shared on April 27th 2022 and its information was last updated May 9th 2022."

Answered by AI

To what extent is this clinical trial being conducted with participants?

"Affirmative. Per the information present on clinicaltrials.gov, this trial is actively enrolling subjects at this time. It was initially posted on April 27th 2022 and has since been updated May 9th of that same year. The study requires 100 participants from a single medical site to be recruited in total."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Human Papillomavirus Education Programs

Electra Paskett 2022. "Human Papillomavirus Education Programs". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04880837.